Cited by 209Advanced Glycation End Products researchAldose Reductase and TaurineChronic Kidney Disease and Diabetes

Unlocking the biology of RAGE in diabetic microvascular complications

Open access
Manigrasso, Michaele B., Juranek, Judyta, Ramasamy, Ravichandran, Schmidt, Ann Marie·2014·Trends in Endocrinology & Metabolism

Abstract

The discovery of the receptor for advanced glycation end-products (RAGE) set the stage for the elucidation of important mechanisms underpinning diabetic complications. RAGE transduces the signals of advanced glycation end-products (AGEs), proinflammatory S100/calgranulins, and high mobility group box 1 (HMGB1), and is a one of a family of receptors for lysophosphatidic acid (LPA). These ligand tales weave a theme of vascular perturbation and inflammation linked to the pathogenesis of the chronic complications of diabetes. Once deemed implausible, this concept of inflammatory cues participating in diabetic complications is now supported by a plethora of experimental evidence in the macro- and microvasculature. We review the biology of ligand-RAGE signal transduction and its roles in diabetic microvascular complications, from animal models to human subjects.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.tem.2013.08.002

Cites

93 of 93 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Research works printed but not linked: 1

  1. [1]International Diabetes Federation IDF Diabetes Atlas 2012 5th edn Brussels, Belgium International Diabetes Federation 35914061

Cited by

Sorted by citations

Authors
Manigrasso, M. B., Juranek, J., Ramasamy, R., & Schmidt, A. M.
Affiliations
NYU Langone Health (US)
Venue
Trends in Endocrinology & Metabolism
Publisher
Elsevier BV
Published
2014-01
Volume
25
Issue
1
Pages
15-22
ISSN
1043-2760 (ISSN-L)
OpenAlex
W2042130085
Cited by
209
References
92
Citations by year
2026: 9 · 2025: 13 · 2024: 13 · 2023: 14 · 2022: 15 · 2021: 19 · 2020: 16 · 2019: 17 · 2018: 11 · 2017: 16 · 2016: 21 · 2015: 22 · 2014: 19 · 2013: 1
FWCI
2.17
Type
journal article
Language
en
Open access
Locations
  • Trends in Endocrinology and Metabolism (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Heart, Lung, and Blood Institute (P01HL060901)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Aldose Reductase and Taurine
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
Keywords
receptor for advanced glycation end products, RAGE, advanced glycation end products, diabetic microvascular complications, S100/calgranulins, high mobility group box 1, lysophosphatidic acid receptor, inflammation, vascular dysfunction, signal transduction, diabetes complications
MeSH terms
Receptor for Advanced Glycation End Products, Formins, Animals, Carrier Proteins, Diabetic Angiopathies, Diabetic Nephropathies, Diabetic Retinopathy, Humans, Hyperglycemia, Inflammation, Kidney, Ligands, Receptors, Immunologic, Signal Transduction, Glycation End Products, Advanced, HMGB1 Protein, Leukocyte L1 Antigen Complex, Diabetes Complications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review